Growth Metrics

Sanara MedTech (SMTI) Net Cash Flow (2016 - 2025)

Sanara MedTech's Net Cash Flow history spans 15 years, with the latest figure at $1.6 million for Q4 2025.

  • For Q4 2025, Net Cash Flow rose 510.94% year-over-year to $1.6 million; the TTM value through Dec 2025 reached $700562.0, down 93.47%, while the annual FY2025 figure was $700562.0, 93.47% down from the prior year.
  • Net Cash Flow reached $1.6 million in Q4 2025 per SMTI's latest filing, up from -$2.0 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $26.9 million in Q1 2021 to a low of -$3.7 million in Q2 2025.
  • Average Net Cash Flow over 5 years is $806174.6, with a median of -$1.5 million recorded in 2022.
  • Peak YoY movement for Net Cash Flow: plummeted 309.89% in 2021, then soared 5664.22% in 2024.
  • A 5-year view of Net Cash Flow shows it stood at -$3.7 million in 2021, then soared by 64.33% to -$1.3 million in 2022, then grew by 17.92% to -$1.1 million in 2023, then skyrocketed by 63.36% to -$398894.0 in 2024, then soared by 510.94% to $1.6 million in 2025.
  • Per Business Quant, the three most recent readings for SMTI's Net Cash Flow are $1.6 million (Q4 2025), -$2.0 million (Q3 2025), and -$3.7 million (Q2 2025).